EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Arid1a Loss Enhances Disease Progression in a Murine Model of Osteosarcoma

Kaniz Fatema iD, Yanliang Wang, Adriene Pavek, Zachary Larson, Christopher Nartker, Shawn Plyler, Amanda Jeppesen, Breanna Mehling, Mario R Capecchi, Kevin B Jones, Jared J Barrott iD

Cancers · 31.07.2024 · 16 (15) · 2725

DOI: 10.3390/cancers16152725 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 31.07.2024. Verfasst von Kaniz Fatema und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma is an aggressive bone malignancy, molecularly characterized by acquired genome complexity and frequent loss of TP53 and RB1. Obtaining a molecular understanding of the initiating mutations of osteosarcomagenesis has been challenged by the difficulty of parsing between passenger and driver mutations in genes. Here, a forward genetic screen in a genetic mouse model of osteosarcomagenesis initiated by Trp53 and Rb1 conditional loss in pre-osteoblasts identified that Arid1a loss contributes to OS progression. Arid1a is a member of the canonical BAF (SWI/SNF) complex and a known tumor suppressor gene in other cancers. We hypothesized that the loss of Arid1a increases the rate of tumor progression and metastasis. Phenotypic evaluation upon in vitro and in vivo deletion of Arid1a validated this hypothesis. Gene expression and pathway analysis revealed a correlation between Arid1a loss and genomic instability, and the subsequent dysregulation of genes involved in DNA DSB or SSB repair pathways. The most significant of these transcriptional changes was a concomitant decrease in DCLRE1C. Our findings suggest that Arid1a plays a role in genomic instability in aggressive osteosarcoma and a better understanding of this correlation can help with clinical prognoses and personalized patient care.

Schlagwörter

Stichwörter der Autor:innen

Arid1aDNA damage repairDSBSSBSWI/SNFepigeneticsforward genetic screengenomic instabilityosteosarcomapiggyBac

Autor:innen und Institutionen

  • Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA.
  • Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
  • Department of Orthopaedics, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
  • Huntsman Cancer Institute, Salt Lake City, UT 84112, USA.
  • Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
  • Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USA.

ORCID-Profile: Kaniz Fatema, Jared J Barrott

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NIGMS NIH HHS
  • CSRD VA
  • State of Idaho
  • the INBRE PROGRAM, NIH
  • Almac Diagnostics Partnership Award
  • Idaho State Career Path Internships

Zitieren

APA

Fatema, K., Wang, Y., Pavek, A., Larson, Z., Nartker, C., Plyler, S., Jeppesen, A., Mehling, B., Capecchi, M. R., Jones, K. B., & Barrott, J. J. (2024). Arid1a Loss Enhances Disease Progression in a Murine Model of Osteosarcoma. Cancers, 16(15), 2725. https://doi.org/10.3390/cancers16152725

Vancouver

Fatema K, Wang Y, Pavek A, Larson Z, Nartker C, Plyler S, et al. Arid1a Loss Enhances Disease Progression in a Murine Model of Osteosarcoma. Cancers. 2024;16(15):2725. doi:10.3390/cancers16152725

BibTeX
@article{Fatema2024,
  author = {Fatema, Kaniz and Wang, Yanliang and Pavek, Adriene and Larson, Zachary and Nartker, Christopher and Plyler, Shawn and Jeppesen, Amanda and Mehling, Breanna and Capecchi, Mario R and Jones, Kevin B and Barrott, Jared J},
  title = {Arid1a Loss Enhances Disease Progression in a Murine Model of Osteosarcoma},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {15},
  pages = {2725},
  doi = {10.3390/cancers16152725}
}
Kostenlos starten →